Atika Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Atika Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,950	Closed	-$662K	–	59
2015 Q2	$662K	Buy	5,950 +950	+19%	+$102K	0.3%	64
2015 Q1	$471K	Sell	5,000 -22,000	-81%	-$2.47M	0.31%	59
2014 Q4	$3.02M	Sell	27,000 -27,000	-50%	-$2.41M	2.21%	14
2014 Q3	$3.31M	Buy	54,000 +42,000	+350%	+$1.81M	2.55%	11
2014 Q2	$550K	Sell	12,000 -14,250	-54%	-$581K	0.45%	54
2014 Q1	$1.03M	Buy	+26,250	New	+$878K	0.88%	45

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Atika Capital Management's AGIO Position: Q3 2015 in Review

Atika Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2015, closing a stake of 5,950 shares — an estimated $662K sold.

Atika Capital Management first reported a position in AGIO in Q1 2014 and held it in 6 quarters. The position peaked at $3.31M in Q3 2014. 150 funds tracked by Wall St. Rank hold AGIO as of Q3 2015.

Atika Capital Management reported no remaining Agios Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Atika Capital Management sold 5,950 Agios Pharmaceuticals shares in Q3 2015, an estimated $662K.
Atika Capital Management first reported a position in Agios Pharmaceuticals in Q1 2014 and held it in 6 quarters.
Atika Capital Management's Agios Pharmaceuticals position peaked at $3.31M in Q3 2014.
150 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2015.

Based on Atika Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.